Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-27 Purchase |
2024-09-27 4:26 pm |
BioAge Labs Inc. | BIOA | ENRIGHT PATRICK G Director |
400,000 | $18 | $7,200,000 | 1,725,589 (Indirect Direct) |
View |
| 2024-09-16 Purchase |
2024-09-16 8:57 pm |
Zenas BioPharma Inc. | ZBIO | ENRIGHT PATRICK G Director |
440,000 | $17 | $7,480,000 | 811,530 (Indirect Direct) |
View |
| 2023-11-07 Purchase |
2023-11-09 8:32 pm |
Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
454,545 | $11 | $4,999,995 | 2,567,100 (Indirect) |
View |
| 2023-08-14 Sale |
2023-08-15 5:45 pm |
Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director |
1,241 | $138.16 | $171,455 | 20,946 (Direct) |
View |
| 2023-02-06 Purchase |
2023-02-08 7:32 pm |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
1,714,285 | $7 | $11,999,995 | 5,144,212 (Indirect) |
View |
| 2022-11-22 Sale |
2022-11-25 9:33 pm |
Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director |
6,974 | $150.45 | $1,049,264 | 19,112 (Indirect Direct) |
View |
| 2022-08-08 Sale |
2022-08-09 6:12 pm |
Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director |
1,089 | $152.33 | $165,883 | 26,086 (Indirect Direct) |
View |
| 2022-04-19 Purchase |
2022-04-21 6:04 pm |
Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
1,355,000 | $3.69 | $4,999,950 | 4,174,379 (Indirect) |
View |
| 2022-02-10 Purchase |
2022-04-05 07:22 am |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
333,333 | $15 | $4,999,995 | 3,429,927 (Indirect) |
View |
| 2022-02-02 Purchase |
2022-02-02 9:25 pm |
Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Prime Partners LLC Longitude Prime Fund L.P. 10% Owner |
175,000 | $27 | $4,725,000 | 2,139,771 (Indirect) |
View |
| 2021-07-19 Purchase |
2021-07-20 9:39 pm |
RAPID MICRO BIOSYSTEMS INC. | RPID | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Longitude Prime Partners LLC Longitude Prime Fund L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner |
150,000 | $20 | $3,000,000 | 779,032 (Indirect) |
View |
| 2021-05-18 Purchase |
2021-05-18 8:14 pm |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
909,090 | $11 | $9,999,990 | 3,096,594 (Indirect) |
View |
| 2021-05-11 Purchase |
2021-05-11 8:29 pm |
Talaris Therapeutics Inc. | TALS | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner |
235,000 | $17 | $3,995,000 | 3,220,775 (Indirect) |
View |
| 2020-11-12 Sale |
2020-11-13 4:56 pm |
Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director |
9,929 | $146.72 | $1,456,738 | 20,368 (Direct) |
View |
| 2020-10-20 Purchase |
2020-10-22 8:24 pm |
Eargo Inc. | EAR | Longitude Venture Partners IV L.P. ENRIGHT PATRICK G Longitude Capital Partners IV LLC 10% Owner |
233,333 | $18 | $4,199,994 | 3,918,691 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director |
7,840 | $34.5 | $270,480 | 0 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-09-27 Conversion |
2024-09-27 4:26 pm |
N/A N/A |
BioAge Labs Inc. | BIOA | ENRIGHT PATRICK G Director |
7,159,226 | $0 | 1,725,589 (Indirect) |
View |
| 2024-09-25 Option Award |
2024-09-27 4:26 pm |
N/A 2034-09-24 |
BioAge Labs Inc. | BIOA | ENRIGHT PATRICK G Director |
15,000 | $0 | 1,725,589 (Direct) |
View |
Ownership |
2024-09-25 4:52 pm |
N/A N/A |
BioAge Labs Inc. | BIOA | ENRIGHT PATRICK G Director |
0 | $0 | 1,310,589 (Indirect) |
View |
| 2024-09-16 Conversion |
2024-09-16 8:57 pm |
N/A N/A |
Zenas BioPharma Inc. | ZBIO | ENRIGHT PATRICK G Director |
19,965,924 | $0 | 811,530 (Indirect) |
View |
| 2024-09-12 Option Award |
2024-09-16 8:57 pm |
N/A 2034-09-11 |
Zenas BioPharma Inc. | ZBIO | ENRIGHT PATRICK G Director |
37,000 | $0 | 811,530 (Direct) |
View |
Ownership |
2024-09-12 9:42 pm |
N/A N/A |
Zenas BioPharma Inc. | ZBIO | ENRIGHT PATRICK G Director |
0 | $0 | 2,061,934 (Indirect) |
View |
| 2024-08-02 Option Award |
2024-08-06 6:45 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director |
3,731 | $0 | 24,677 (Direct) |
View |
| 2024-05-15 Option Award |
2024-05-17 4:10 pm |
N/A 2034-05-14 |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2023-11-07 Conversion |
2023-11-09 8:32 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
24,018,702 | $0 | 2,567,100 (Indirect) |
View |
Ownership |
2023-11-02 9:36 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
0 | $0 | 2,067,743 (Indirect) |
View |
| 2023-08-11 Option Award |
2023-08-15 5:45 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director |
3,075 | $0 | 20,946 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-12 4:12 pm |
N/A 2033-05-09 |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-08-05 Option Award |
2022-08-09 6:12 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director |
2,561 | $0 | 26,086 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-31 4:30 pm |
N/A 2032-05-25 |
Aptinyx Inc. | APTX | ENRIGHT PATRICK G Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:13 pm |
N/A 2032-05-23 |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
9,925 | $0 | 9,925 (Direct) |
View |
| 2022-04-27 Other |
2022-04-29 7:07 pm |
N/A N/A |
Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Prime Partners LLC Longitude Prime Fund L.P. 10% Owner |
2,155,801 | $0 | 2,163,816 (Indirect) |
View |
| 2022-01-25 Exercise |
2022-01-27 9:23 pm |
2020-01-22 2022-04-10 |
Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
1,964,576 | $13.2 | 1,964,771 (Indirect) |
View |
| 2021-08-18 Option Award |
2021-08-20 7:12 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director |
2,000 | $137.75 | 24,614 (Indirect) |
View |
| 2021-07-29 Option Award |
2021-08-02 6:10 pm |
N/A N/A |
Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director |
2,246 | $0 | 22,614 (Direct) |
View |
| 2021-07-19 Conversion |
2021-07-20 9:39 pm |
N/A N/A |
RAPID MICRO BIOSYSTEMS INC. | RPID | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Longitude Prime Partners LLC Longitude Prime Fund L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner |
23,838,431 | $0 | 779,032 (Indirect) |
View |
Ownership |
2021-07-14 7:35 pm |
N/A N/A |
RAPID MICRO BIOSYSTEMS INC. | RPID | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner |
0 | $0 | 6,558,675 (Indirect) |
View |
| 2021-05-27 Option Award |
2021-06-01 4:31 pm |
N/A 2031-05-26 |
Aptinyx Inc. | APTX | ENRIGHT PATRICK G Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-05-18 Conversion |
2021-05-18 8:14 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
2,187,504 | $0 | 3,096,594 (Indirect) |
View |
| 2021-05-13 Option Award |
2021-05-17 8:36 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
9,925 | $0 | 9,925 (Direct) |
View |
Ownership |
2021-05-13 7:18 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
0 | $0 | 2,187,504 (Indirect) |
View |
| 2021-05-11 Conversion |
2021-05-11 8:29 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner |
5,971,550 | $0 | 3,220,775 (Indirect) |
View |
Ownership |
2021-05-06 9:25 pm |
N/A N/A |
Talaris Therapeutics Inc. | TALS | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner |
0 | $0 | 2,985,775 (Indirect) |
View |
| 2021-04-14 Other |
2021-04-15 9:00 pm |
N/A N/A |
Eargo Inc. | EAR | Longitude Venture Partners IV L.P. Longitude Capital Partners IV LLC ENRIGHT PATRICK G 10% Owner |
1,005,012 | $0 | 3,928,715 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:31 pm |
N/A 2030-12-30 |
Aptinyx Inc. | APTX | ENRIGHT PATRICK G Director |
8,149 | $2.224 | 8,149 (Direct) |
View |
| 2020-11-16 Other |
2020-11-18 7:11 pm |
N/A N/A |
89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
855,944 | $0 | 856,835 (Indirect) |
View |
| 2020-11-02 Exercise |
2020-11-04 7:26 pm |
2020-11-02 2020-11-02 |
Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director |
9,929 | $0 | 30,297 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-22 8:24 pm |
N/A N/A |
Eargo Inc. | EAR | Longitude Venture Partners IV L.P. ENRIGHT PATRICK G Longitude Capital Partners IV LLC 10% Owner |
3,685,358 | $0 | 3,918,691 (Direct) |
View |
Ownership |
2020-10-15 9:55 pm |
N/A N/A |
Eargo Inc. | EAR | Longitude Venture Partners IV L.P. ENRIGHT PATRICK G 10% Owner |
0 | $0 | 3,685,358 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director |
162,258 | $34.5 | 0 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-02 3:05 pm |
N/A 2030-09-29 |
Aptinyx Inc. | APTX | ENRIGHT PATRICK G Director |
8,379 | $2.163 | 8,379 (Direct) |
View |
| 2020-09-21 Other |
2020-09-23 9:35 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director |
6,204,831 | $0 | 6,374,929 (Indirect) |
View |